Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.13
Bid: 4.50
Ask: 5.99
Change: 0.00 (0.00%)
Spread: 1.49 (33.111%)
Open: 5.13
High: 0.00
Low: 0.00
Prev. Close: 5.13
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Closes Slightly Higher Amid Iraqi Tensions

Thu, 12th Jun 2014 16:37

LONDON (Alliance News) - The FTSE 100 closed fractionally higher Thursday, having spent the day trading within a tight range, with oil and gas exploration and production company BG Group leading the gains as the price of oil climbed amid escalating violence in Iraq.

BG Group ended the day as the biggest riser in the blue-chip index, closing up 2.5%, benefiting from the increasing price of oil while not itself having any operations in Iraq exposed to the unrest.

Brent and West Texas Intermediate oil prices jumped sharply amid escalating violence in Iraq, where militants are fighting towards Baghdad. At the UK equity market close, Brent was trading up 1.9% at USD112.14 per barrel, while WTI was up 1.5% at USD105.96 per barrel.

A session of the Iraqi parliament called to vote on declaring a nationwide state of emergency has been adjourned due to lack of quorum, even as radical jihadists pressed ahead towards the capital of Baghdad. No date has been set for the next parliamentary meeting, independent Alsumaria TV said, a fiasco set to deepen Iraq's political and security woes.

In the latest developments, the Islamic State in Iraq and the Levant claims on Twitter that it has captured 4,500 Iraqi soldiers in Salah al-Din province, north of Baghdad. Videos posted on YouTube by apparent ISIL supporters showed a column of hundreds of unarmed men in civilian clothes being marched along a highway.

"The unrest in the country has raised fears over supply of crude from the region," said Fawad Razaqzada, a technical analyst at Forex.com. "The situation in Libya also remains out of control where many oilfields and oil export terminals remain under the occupancy of armed insurgents. Should the situation in these countries deteriorate, or worse spread to the neighbours, crude price could potentially climb further higher," he added.

The violence has not been beneficial for all oil and gas companies, however, with Afren and Gulf Keystone, both of which operate in Iraq, closing down 1.7% and 1.8%, respectively, after falling sharply Wednesday as well.

Overall, UK stocks closed mixed Thursday. The FTSE 100 closed up 0.1% at 6,843.11, the FTSE 250 closed up 0.2% at 16,125.95, and the AIM All-Share index closed down 0.5% at 795.18.

In Europe, the CAC 40 in Paris closed down 0.02%, and the DAX 30 in Frankfurt closed down 0.1%.

Meanwhile, on Wall Street, at the UK equity market close, the DJIA, S&P 500, and NASDAQ Composite were all down between 0.2% and 0.3%.

Prior to the NY open, US stock futures had been pointing to a marginally higher open, but turned negative shortly after the latest batch of US data came in below expectations.

US retail sales expanded by 0.3% in the month of May, following an upwardly revised 0.5% increase in April. Economists had been expecting sales to climb by about 0.6% in May compared with the 0.1% uptick originally reported for the previous month. Excluding car sales, retail sales were up by just 0.1% over the month, compared with a 0.4% increase in April. Ex-auto sales were originally reported as unchanged in the previous month.

Initial jobless claims, released at the same time, also disappointed, rising to 317,000 in the week ended June 6, from 313,000 in the previous week, more than the 310,000 that economists had forecast.

In the forex market, the dollar softened across the board Thursday. At the close of the UK equity market, the dollar was trading at JPY101.840, while the pound was at USD1.6848 and the euro at USD1.3551.

Mining companies Anglo American, Rio Tinto, Glencore and BHP Billiton were all amongst the heaviest blue-chip fallers Thursday, amid concerns over commodity prices and consequential share price target reductions by analysts at Morgan Stanley.

Morgan Stanley’s metals and minerals commodity economist Joel Crane lowered his iron-ore price assumptions for 2014 to 2019. For the second half of the current year, the analyst cut Morgan Stanley's assumed iron ore price by more than 17% to USD95 per metric ton. For the 2015 full-year, the assumed price has been slashed by almost 24% to USD87. The long-term price for 2020 and beyond remains unchanged at USD99 per metric ton in real terms, meaning adjusted for inflation.

"The cuts reflect a faster and more pronounced mean reversion in the iron ore price in reaction to accelerating supply growth than we anticipated," Morgan Stanley said in a morning note to investors.

Morgan Stanley downgraded Anglo American to Underweight from Equal Weight, lowering its price target to 1,360.00 pence from 1,530.00p, saying that the market is too optimistic on the miner's cost reduction plans, and that its exposure to iron ore exceeds that of other miners. It also lowered BHP Billiton's price target to 2,200.00 pence from 2,140.00p, and Rio Tinto's 3,430.00 pence from 3,820.00p.

Anglo American closed down 3.2%, Rio Tinto down 3.1%, BHP Billiton down 1.8%, and Glencore down 1.3%. The FTSE 350 mining sector index closed down 1.9% at a near three-month low.

The downgrade was enough to see Anglo American end the day as the biggest faller in the FTSE 100, even though FTSE 250-listed Lonmin said it had reached a tentative deal over wages and working conditions with the leadership of the union that has crippled the South African platinum mining industry for several months.

The company said the two sides have reached "informal undertakings" in principle on a potential deal. Peers Anglo American Platinum, part of Anglo American, and Impala Platinum Holding have received the same in principle undertakings, it added.

"The companies expect to receive feedback from the Association of Mineworkers and Construction Union on Friday, 13 June. Thereafter, and should an agreement be reached, the companies will be assisting employees to ensure a safe return to a normal working environment," Lonmin said.

Lonmin, which had moved lower in early trade, managed to end the day up 8.9% as the mid-cap index's biggest riser, following the announcement.

Elsewhere, ITV ended the day as one of the biggest risers in the FTSE 100, closing up 1.6%. Shares in the television company rose after trade magazine Media Week reported that US advertising and marketing agency Omnicom Group Inc has decided to halt all media spend with Channel 5 until the end of the year, redirecting advertising activity to ITV instead.

The move is reported to have been made without any discussions with Channel 5, with many in the industry suggesting that ITV is receiving the extra spend due to its relationship with Omnicom's media trading arm Opera, the magazine reported.

Opera is said to have spent more than GBP50 million on Channel 5 last year.

"ITV looks to have gained a major boost, with one of the main media buying groups reportedly stopping spending with Channel 5 in the second half of the year and shifting this money across to ITV," said Liberum Capital analyst Ian Whittaker.

Earlier in the day, Whittaker sent a research note to investors saying that the fact ITV's shares have spent June trading in tight ranges should be used as a buying opportunity. "While we like it for long-term, fundamental reasons, shorter-term advertising trends also provide a catalyst," Whittaker said. "In this context, the suggestions that advertising momentum is improving around the World Cup should help," he said.

Imperial Tobacco Group, closing up 0.9%, was another big winner. The company's shares moved higher after Reuters reported that the group is considering a deal to buy assets that are likely to be sold by US tobacco companies Reynolds American Inc and Lorillard Inc if they go ahead with a proposed merger.

AstraZeneca ended the day up 0.5%. The pharmaceuticals giant said it had signed a global licence agreement with AIM-listed biotechnology company Synairgen for its SNG001 compound for the treatment of infections that exacerbate asthma. Under the terms of the deal, AstraZeneca will pay Synairgen an up-front free of USD7.25 million, with potential milestone payments of up to USD225 million possible.

Separately, AstraZeneca and Amgen said late Wednesday that phase II study results of psoriatic arthritis drug brodalumab showed that the treatment showed significant improvement in clinical symptoms.

The results, which were published in the New England Journal of Medicine, and will be presented at the 2014 European League Against Rheumatism congress in June, also showed that many patients continued to improve and saw sustained improvements. The companies said that the encouraging data from the study was why they had opted to continue developing brodalumab as a potential treatment for psoriatic arthritis.

In the FTSE 250, Halma, closing up 4%, was one of the index's riser. The technology company upped its total dividend for the year to end-March and expressed confidence for further growth in the year ahead, as it saw pretax profit rise, boosted by strong revenue growth in the US, UK and mainland Europe.

It posted a pretax profit of GBP138.7 million, up 15% from GBP120.1 million, as it saw revenue rise 9.3% to GBP676.5 million from GBP619.2 million. It proposed a total dividend of 11.17 pence, up 7.1% from 10.43p in the previous year.

Also in the mid-cap index, Premier Farnell closed up 3.3% after it said it will restructure its business for an estimated cost of GBP8 million to secure yearly cost savings of GBP6 million to GBP8 million. It said the cost benefits will be minimal in the current financial year, with the full benefit anticipated for the 2016 financial year. The company also said it was continuing to trade in line with its forecast at the time of its interim management statement in May.

Still to come Thursday, Bank of England Governor Mark Carney and Chancellor of the Exchequer George Osborne are due to give speeches at a Mansion House dinner.

“Given recent firmer economic data, the tone of these will probably be more upbeat than in recent years,” said Rhys Herbert, senior economist at Lloyds Bank. While it is unlikely that either will use the occasion to announce new initiatives, markets will be looking for any hints of possible action from the Financial Policy Committee, Herbert added.

In the data calendar on Friday, the Bank of Japan releases its latest interest rate decision and monetary policy statement at 0400 BST. Japanese industrial production and capacity utilisation data for April are released at 0530 BST, shortly before Chinese industrial production, retail sales, and urban investment data for May at 0630 BST.

German consumer price inflation figures are released at 0700 BST, with the Spanish and Italian equivalents due at 0800 BST and 0900 BST, respectively. Employment change and trade balance data for the eurozone is scheduled for 1000 BST.

In the US, producer price inflation is published at 1330 BST, with the preliminary Reuters/Michigan consumer sentiment index released at 1455 BST.

In the corporate calendar, AIM All-Share index-listed Bonmarche Holdings is due to release full-year results Friday.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2023 11:19

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints Joseph Colliver as chief financial officer with effect from November 6. Current CFO John Ward will step down from his role on November 3. Colliver has previously held CFO and senior commercial roles at Sativa Group Inc, and within the Kantar division of WPP PLC. He is currently CFO at Phytome Life Sciences Ltd, a pharmaceutical manufacturing firm focused on plant-based medicines.

Read more
11 Oct 2023 10:26

Synairgen names Joseph Colliver as CFO

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.

Read more
3 Oct 2023 09:59

Synairgen promotes Marcin Mankowski to chief medical officer

(Alliance News) - Synairgen PLC on Tuesday promoted Marcin Mankowski to chief medical officer, effective immediately.

Read more
21 Sep 2023 13:48

IN BRIEF: Synairgen narrows interim loss on reduced R&D spending

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Pretax loss narrows to GBP5.2 million in six months that ended June 30 from GBP14.0 million a year before. Has no revenue either year, but research and development spending is reduced to GBP3.5 million from GBP11.1 million, as phase 3 Sprinter trial of SNG001 is mostly completed in 2022. Since the start of the second half, receives GBP2.4 million R&D tax credit, which adds to GBP14.6 million cash balance on June 30.

Read more
22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:44

EARNINGS SUMMARY: Synairgen loss narrows; aims to develop SNG001

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
20 Apr 2023 15:41

UK earnings, trading statements calendar - next 7 days

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
23 Dec 2022 17:05

TRADING UPDATES: SulNOx raises funds; Synairgen shares trial results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
4 Oct 2022 10:53

Synairgen test results positive but not "statistically significant"

(Alliance News) - Synairgen PLC on Tuesday said it had received positive data from its ACTIV-2 Phase 2 trial for its antiviral treatment.

Read more
4 Oct 2022 08:00

Synairgen posts positive results for phase 2 trial with SNG001 against Covid-19

(Sharecast News) - Synairgen announced positive results for its inhaled antiviral protein treatment interferon beta against Covid-19.

Read more
29 Sep 2022 20:30

EARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Sep 2022 15:48

UK earnings, trading statements calendar - next 7 days

Friday 23 September 
Biffa PLCTrading Statement
European Opportunities Trust PLCFull Year Results
Investec PLCTrading Statement
Smiths Group PLCFull Year Results
TheWorks.co.uk PLCFull Year Results
Monday 26 September 
Atome Energy PLCHalf Year Results
Chapel Down Group PLCHalf Year Results
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Devolver Digital IncHalf Year Results
Dillistone Group PLCHalf Year Results
Finsbury Food Group PLCFull Year Results
Frenkel Topping Group PLCHalf Year Results
Immotion Group PLCHalf Year Results
Likewise Group PLCHalf Year Results
Microlise Group PLCHalf Year Results
Next Fifteen Communications PLCHalf Year Results
SpaceandPeople PLCHalf Year Results
XLMedia PLCHalf Year Results
Xpediator PLCHalf Year Results
Tuesday 27 September 
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Boku IncHalf Year Results
Card Factory PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Diaceutics PLCHalf Year Results
Digitalbox PLCHalf Year Results
ECSC Group PLCHalf Year Results
Ergomed PLCHalf Year Results
Ferguson PLCFull Year Results
FireAngel Safety Technology Group PLCHalf Year Results
GENinCode PLCHalf Year Results
Gresham House Energy Storage Fund PLCHalf Year Results
K3 Capital Group PLCFull Year Results
Instem PLCHalf Year Results
LifeSafe Holdings PLCHalf Year Results
Medica Group PLCHalf Year Results
Mission Group PLCHalf Year Results
Mortgage Advice Bureau PLCHalf Year Results
NAHL Group  PLCHalf Year Results
Origin Enterprises PLCFull Year Results
United Utilities Group PLCTrading Statement
Personal Group Holdings PLCHalf Year Results
S&U PLCHalf Year Results
Saga PLCHalf Year Results
Serica Energy PLCHalf Year Results
SSP Group PLCTrading Statement
tinyBuild IncHalf Year Results
Transense Technologies PLCFull Year Results
Yu Group PLCHalf Year Results
Wednesday 28 September 
1Spatial PLCHalf Year Results
AVI Japan Opportunity Trust PLCHalf Year Results
Avingtrans PLCFull Year Results
Blancco Technology Group PLCFull Year Results
boohoo Group PLCHalf Year Results
Everyman Media Group PLCHalf Year Results
Octopus Renewables Infrastructure Trust PLCHalf Year Results
Shepherd Neame LtdFull Year Results
Skillcast Group PLCHalf Year Results
SolGold PLCFull Year Results
Thursday 29 September 
Allergy Therapeutics PLCFull Year Results
Angle PLCHalf Year Results
Avation PLCFull Year Results
Bango PLCHalf Year Results
Cap-XX LtdHalf Year Results
Celadon Pharmaceuticals PLCHalf Year Results
Crestchic PLCHalf Year Results
Directa Plus PLCTrading Statement
McBride PLCFull Year Results
NAHL Group PLCHalf Year Results
Next PLCHalf Year Results
Novacyt SAHalf Year Results
Physiomics PLCFull Year Results
Synairgen PLCHalf Year Results
XLMedia PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Sep 2022 10:30

IN BRIEF: Synairgen shares rise as positive data found for COPD

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Posts positive from its Phase 2 clinical trial of inhaled SNG001 in virally infected chronic obstructive pulmonary disease patients. Says findings from assessments of lung sputum samples show viral clearance from the lower respiratory tract. SNG001 is a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta.

Read more
7 Sep 2022 07:59

Synairgen unveils positive clinical trial data

(Sharecast News) - Respiratory drug discovery firm Synairgen has announced positive findings from a clinical trial into its experimental antiviral treatment.

Read more
5 Sep 2022 18:25

TRADING UPDATES: Bradda wins drilling approval; Oakley invests in vLex

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.